跳至主要内容
临床试验/ACTRN12612001310853
ACTRN12612001310853已完成未知

Obervational Study on the Effectiveness of Intravitreal Aflibercept in Exudative Age-related Macular Degeneration Patients

Sydney Retina Clinic and Day Surgery0 个研究点目标入组 200 人开始时间: 2012年12月18日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 o limit(—)
性别
All

入选标准

  • 1) Previously or currently being treated with, or initiating treatment, with aflibercept for exudative AMD; and
  • 2) Ability to provide informed consent and complete study assessments

排除标准

  • Pregnancy or lactation
  • Premenopausal women not using contraception
  • Prior anti-VEGF injection in the study eye within 28 days of baseline
  • Prior treatment with photo dynamic therapy (PDT) within 90 days of baseline and more than 6 prior PDT treatments
  • Significant subretinal fibrosis or atrophy
  • Prior treatment with triamcinolone in the study eye within 6 months of baseline
  • Intraocular surgery in the study eye within 2 months of baseline
  • Simultaneous participation in a study that includes administration of any investigational drug or procedures.

研究者

发起方
Sydney Retina Clinic and Day Surgery

相似试验